08.10.15
Natreon, Inc., New Brunswick, NJ, has received a new patent for the isolation, purification and synthesis of Indolealkylamino-withasteroid conjugates from Sensoril (Withania somnifera) with potential benefits for Alzheimer’s Disease.
Natreon’s Sensoril (Withania somnifera), also known as Ashwagandha in Ayurveda, is a potent adaptogen used to promote health and longevity by augmenting the body’s defense mechanisms against disease, arresting the aging process, revitalizing the body in debilitated conditions, and creating a sense of well-being, the company said. Several earlier human clinical studies have shown that Sensoril is very effective in decreasing stress levels and improving cognition. This latest patent describes a group of indolealkylamino-withasteroid conjugates isolated from Withania somnifera and purified for possible treatment of dementia and dementia-related disorders, such as Alzheimer’s Disease, anxiety, and depressive disorders in a patient.
Natreon’s Sensoril (Withania somnifera), also known as Ashwagandha in Ayurveda, is a potent adaptogen used to promote health and longevity by augmenting the body’s defense mechanisms against disease, arresting the aging process, revitalizing the body in debilitated conditions, and creating a sense of well-being, the company said. Several earlier human clinical studies have shown that Sensoril is very effective in decreasing stress levels and improving cognition. This latest patent describes a group of indolealkylamino-withasteroid conjugates isolated from Withania somnifera and purified for possible treatment of dementia and dementia-related disorders, such as Alzheimer’s Disease, anxiety, and depressive disorders in a patient.
